Viewing StudyNCT04745689

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04745689
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-12-15
First Post: 2020-12-16
Brief Title: Study of AZD2811 Durvalumab in ES-SCLC
Sponsor: AstraZeneca
Organization: AstraZeneca
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Small-Cell Lung Cancer
Keywords:
Name View
ES-SCLC View
Extensive Stage Small-Cell Lung Cancer View
Carcinoma Small Cell Lung View
Oat Cell Carcinoma of Lung View
Oat Cell Lung Cancer View
Small Cell Cancer Of The Lung View
Small Cell Lung Cancer View
SCLC View